What are the side effects of loxapine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Side Effects of Loxapine

Loxapine causes frequent extrapyramidal symptoms (tremor, rigidity, akathisia) and sedation, with a side effect profile similar to typical antipsychotics, including risks of tardive dyskinesia, neuroleptic malignant syndrome, and cardiovascular effects. 1

Neurological and Movement Disorders

Extrapyramidal Symptoms (EPS)

  • Parkinsonian symptoms occur frequently, particularly during the first few days of treatment, manifesting as tremor, rigidity, excessive salivation, and masked facies 1
  • Akathisia (motor restlessness) is reported relatively frequently and can be controlled by dose reduction or antiparkinson medications 1
  • Acute dystonia may develop in susceptible individuals during initial treatment days, presenting as prolonged muscle contractions, neck spasms progressing to throat tightness, swallowing difficulty, breathing problems, and tongue protrusion 1
  • Males and younger patients face elevated risk for acute dystonic reactions 1
  • Loxapine causes a high incidence of extrapyramidal reactions comparable to phenothiazines and butyrophenones 2
  • When compared to atypical antipsychotics, loxapine produces significantly more extrapyramidal adverse effects (RR 2.18,95% CI 1.6-3.1) 3

Tardive Dyskinesia

  • Persistent tardive dyskinesia may appear during long-term therapy or after discontinuation, with greater risk in elderly patients on high-dose therapy, especially females 1
  • The syndrome manifests as rhythmical involuntary movements of tongue, face, mouth, or jaw (tongue protrusion, cheek puffing, mouth puckering, chewing movements), sometimes accompanied by extremity movements 1
  • No known effective treatment exists for tardive dyskinesia; antiparkinson agents do not alleviate symptoms 1
  • Fine vermicular tongue movements may signal early syndrome development 1

Neuroleptic Malignant Syndrome (NMS)

  • NMS has been reported with loxapine, presenting as altered mental status, hyperthermia, severe rigidity, and autonomic instability 1
  • Risk factors include dehydration, physical exhaustion, preexisting brain disease, and concomitant psychotropic medications 4

Cardiovascular Effects

  • Tachycardia, hypotension, hypertension, orthostatic hypotension, lightheadedness, and syncope have been reported 1
  • Rare cases of ECG changes similar to phenothiazines have occurred, though causality with loxapine remains uncertain 1
  • Tachycardia occurs frequently, especially during early treatment stages 2

Sedation and Cognitive Effects

  • Sedation occurs frequently, particularly during early treatment stages 2, 3
  • Drowsiness is a chief side effect, especially in elderly patients 5

Anticholinergic Effects

  • Dry mouth, nasal congestion, constipation, blurred vision, urinary retention, and paralytic ileus have been reported 1
  • These anticholinergic effects occur less commonly than EPS but follow patterns seen with older antipsychotics 2

Hematologic Effects

  • Rarely, agranulocytosis, thrombocytopenia, and leukopenia may occur 1

Dermatologic Effects

  • Dermatitis, facial edema (puffiness), pruritus, rash, alopecia, and seborrhea have been documented 1

Gastrointestinal and Hepatic Effects

  • Nausea and vomiting occur in some patients 1
  • Hepatocellular injury with SGOT/SGPT elevation has been reported, and rarely jaundice and/or hepatitis questionably related to loxapine 1

Endocrine and Metabolic Effects

  • Weight gain or weight loss may occur 1
  • Rarely, galactorrhea, amenorrhea, gynecomastia, and menstrual irregularities of uncertain etiology have been reported 1

Other Effects

  • Dyspnea, ptosis, hyperpyrexia, flushed facies, headache, paresthesia, and polydipsia have been documented 1
  • Precipitation of epileptic seizures can occur, similar to older antipsychotic drugs 2
  • Slight increase in blood pressure has been observed in elderly patients 5

Dosing Considerations for Side Effect Management

  • Most extrapyramidal symptoms are not severe and can be controlled by dose reduction or administration of antiparkinson drugs 1
  • In elderly patients, therapeutic dosage range is 10-80 mg daily—approximately half that used for younger patients—which may reduce side effect burden 5

Comparative Side Effect Profile

  • Loxapine's adverse effect profile is similar to typical antipsychotics rather than atypicals 3, 6
  • At high doses for chronic treatment, loxapine demonstrates an adverse effects profile comparable to typical antipsychotics 6

References

Research

Loxapine for schizophrenia.

The Cochrane database of systematic reviews, 2007

Guideline

Adverse Effects of Prochlorperazine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Revisiting loxapine: a systematic review.

Annals of general psychiatry, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.